Rheumatoid Arthritis Work Limitation Factors

Rheumatoid Arthritis Work Limitation Factors Rheumatic and musculoskeletal diseases (RMD) introduce pain and functional limitations into the workplace, affecting individuals with rheumatoid arthritis and osteoarthritis. This study delves into the multifaceted factors that shape the work challenges arising from RMD, acknowledging the broader societal costs involved. By shedding light on these

Rheumatoid Arthritis: Monitoring Disease With Neutrophil-To-Monocyte Ratio

Rheumatoid Arthritis: Monitoring Disease With Neutrophil-To-Monocyte Ratio Overview A recent case-control study conducted in Ibb City, Republic of Yemen, focused on identifying effective hematological markers for monitoring disease activity in patients with chronic rheumatoid arthritis (RA). This autoimmune disease is characterized by chronic inflammation. The study explored three novel inflammatory markers: neutrophil-monocyte

Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases

Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases Pain management is central to the medical practice of many medical professionals, especially rheumatologists and pain experts. Pain intensity has important implications, as it often indicates the severity of a disease, its prognosis, and the outcome of specific treatments. Also, evidence shows

7 Natural Remedies for Rheumatoid Arthritis

Patient Education This article is tailored for patients. Refer your patients to this article for them to learn more about their condition. 7 Natural Remedies for Rheumatoid Arthritis Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. It causes inflammation, pain, and stiffness in the joints, leading to decreased

Golimumab Compliance In Long-Term Arthritis Treatment

Golimumab Compliance In Long-Term Arthritis Treatment STUDY BACKGROUND Biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs) are the cornerstones in treating inflammatory arthritides such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (SpA). Tumor necrosis factor-alpha (TNFα) inhibitors, including adalimumab, infliximab and golimumab are the most commonly prescribed

Rheumatoid Arthritis Work Limitation Factors